Description

Option Care Health’s Clinic Visits Rise Over 20% — A Hidden Growth Engine?

Option Care Health, the largest independent provider of home and alternate site infusion therapy in the United States, reported second quarter 2026 results that reflected operational strength alongside ongoing strategic initiatives. The company generated revenue of $1.4 billion, marking a 2% increase year-over-year and 7% sequential growth. Adjusted EBITDA rose 3% from the prior year to $117.5 million, while adjusted earnings per share advanced by $0.04 to $0.45, with about $0.03 of this improvement attributed to share repurchases. Operating cash flow was strong at $184 million, supported by effective working capital management. The net debt to adjusted EBITDA ratio stood at 2.1 times, indicating a manageable leverage position. Growth was primarily driven by the acute therapy portfolio, which achieved high single-digit organic growth with sequential and year-over-year increases across all major therapeutic categories and patient volumes.